Mayo Clinic

Phenomix Sciences Signs Exclusive Technology Licensing Deal With Mayo Clinic for Obesity Phenotype Blood Test

Retrieved on: 
Tuesday, May 4, 2021
Health, Diabetes, Other Health, Fitness & Nutrition, General Health, Biotechnology, Branches of biology, Systems biology, Amphetamine, Bariatrics, Body shape, Nutrition, Obesity, Metabolomics, Mayo Clinic, Biology

b'Biomedical startup company Phenomix Sciences (Phenomix) has signed an exclusive technology licensing agreement with Mayo Clinic for a novel blood test that accurately predicts obesity phenotypes.

Key Points: 
  • b'Biomedical startup company Phenomix Sciences (Phenomix) has signed an exclusive technology licensing agreement with Mayo Clinic for a novel blood test that accurately predicts obesity phenotypes.
  • The multi-level \xe2\x80\x9comics\xe2\x80\x9d MyPhenome\xe2\x84\xa2 test leverages technology developed at Mayo Clinic to analyze genomics, metabolomics and hormone levels.
  • Its AI-driven algorithmic solution identifies four specific obesity phenotypes to give doctors the ability to prescribe more precise anti-obesity treatments.
  • Obesity has its roots in DNA, but there is also a complicated web connecting obesity to age, race, and gender, as well as education and socioeconomic status.

Altru Health System Strengthens Clinical Trial Offering by Adopting Deep Lens’ Novel AI-Matching Solution, VIPER™

Retrieved on: 
Friday, April 30, 2021
Data management, Other Health, Technology, Pharmaceutical, Practice Management, Oncology, Managed care, Hospitals, Clinical trials, Science, Biotechnology, Software, Other Science, Health, Research, Greater Grand Forks, Altru Health System, Health sciences, Health, Mayo Clinic, Clinical research, Pharmaceutical industry, Clinical trial, Altru Health System, Deep Lens, ALTRU HEALTH SYSTEM, DEEP LENS

b'Deep Lens and Altru Health System today announced a strategic collaboration that will deploy artificial-intelligence (AI)-based clinical trial matching solution, VIPER, into the Altru Health System network.

Key Points: 
  • b'Deep Lens and Altru Health System today announced a strategic collaboration that will deploy artificial-intelligence (AI)-based clinical trial matching solution, VIPER, into the Altru Health System network.
  • VIPER uses proprietary cloud-based technology to facilitate, triage and accelerate the enrollment of patients in the clinical trial recruitment process.
  • VIPER will not only assist in expanding patient access to trials, but the relationship with Deep Lens will allow us to broaden our clinical research program.
  • Altru Health System was the first member of the Mayo Clinic Care Network, extending Mayo Clinic knowledge and expertise to the patients we serve.

TripleBlind Receives Investment from Mayo Clinic, Expanding Current Collaboration

Retrieved on: 
Tuesday, April 27, 2021
Terms of service, Identity management, Privacy, Privacy law, Mayo Clinic, Internet privacy, Minnesota, Articles, Social issues

b'KANSAS CITY, Mo., April 27, 2021 (GLOBE NEWSWIRE) -- Today, TripleBlind announced that it expanded its collaboration with Mayo Clinic , which invested in a seed extension round, the only investor participating.

Key Points: 
  • b'KANSAS CITY, Mo., April 27, 2021 (GLOBE NEWSWIRE) -- Today, TripleBlind announced that it expanded its collaboration with Mayo Clinic , which invested in a seed extension round, the only investor participating.
  • TripleBlind recently announced that it raised $8.2 million in a significantly oversubscribed seed funding round.
  • TripleBlind is not accessing any Mayo Clinic data.\n\xe2\x80\x9cTripleBlind\xe2\x80\x99s API-driven virtual exchange solution accelerates how organizations develop, test and deploy AI solutions in healthcare, and leverage third party data amidst heavily regulated privacy concerns,\xe2\x80\x9d said Riddhiman Das, co-founder and CEO of TripleBlind.
  • It unlocks the estimated 105 petabytes of data stored by enterprises today that are inaccessible and unmonetized due to privacy concerns and regulations.

BioSig’s PURE EP(tm) System Evaluated with Patients at Mayo Clinic in Arizona

Retrieved on: 
Tuesday, April 27, 2021
Mayo Clinic, Mayo, Minnesota, States of the United States

and Luis Scott, M.D.\n\xe2\x80\x9cWe are pleased to expand our installation to a new Mayo Clinic campus, an institution that played, and continues to play, a vital role in defining the clinical value of the PURE EP(tm) System.

Key Points: 
  • and Luis Scott, M.D.\n\xe2\x80\x9cWe are pleased to expand our installation to a new Mayo Clinic campus, an institution that played, and continues to play, a vital role in defining the clinical value of the PURE EP(tm) System.
  • We are thankful to all our physician collaborators and EP fellows at Mayo Clinic and look forward to reporting on more clinical and commercial progress,\xe2\x80\x9d commented Kenneth L. Londoner, Chairman, and CEO of BioSig Technologies, Inc.\nMayo Clinic cares for more than one million people a year, from all 50 states and nearly 140 countries.
  • Investors and security holders are urged to read these documents free of charge on the SEC\xe2\x80\x99s website at http://www.sec.gov.
  • The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.\n'

Leading US hospitals team up to promote COVID-19 vaccination

Retrieved on: 
Tuesday, April 20, 2021
Mayo Clinic, Cleveland Clinic, Fairfax, Cleveland, Health sciences, Health care, Health, COVID-19 vaccine, Organ transplantation

COVID-19 vaccines were evaluated in tens of thousands of participants in clinical trials.

Key Points: 
  • COVID-19 vaccines were evaluated in tens of thousands of participants in clinical trials.
  • Cleveland Clinic has pioneered many medical breakthroughs , including coronary artery bypass surgery and the first face transplant in the United States.
  • U.S. News & World Report consistently names Cleveland Clinic as one of the nation\'s best hospitals in its annual "America\'s Best Hospitals" survey.
  • For information on COVID-19, including Mayo Clinic\'s Coronavirus Map tracking tool, which has 14-day forecasting on COVID-19 trends, visit the Mayo Clinic COVID-19 Resource Center .\n'

Glooko Raises $30 Million Financing Round

Retrieved on: 
Tuesday, March 16, 2021
Glooko, Novo Nordisk, Mayo Clinic, Chronic condition, Life sciences, Companies, Industry economics)

PALO ALTO, Calif., March 16, 2021 /PRNewswire/ -- Glooko Inc. , a leading provider of remote patient monitoring and chronic care management solutions including diabetes and obesity has raised a $30 million Series D round of funding.

Key Points: 
  • PALO ALTO, Calif., March 16, 2021 /PRNewswire/ -- Glooko Inc. , a leading provider of remote patient monitoring and chronic care management solutions including diabetes and obesity has raised a $30 million Series D round of funding.
  • The financing was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic.
  • This round of financing follows a successful 2020 for Glooko, the most successful in its history despite the global pandemic.
  • Glooko has experienced considerable growth, and this funding allows us to build on our strong momentum in providing the advanced technologies we're known for," said Russ Johannesson, CEO of Glooko.

Mayo Clinic Cardiologist, Jay Shah, M.D. Joins MicroSalt Advisory Board

Retrieved on: 
Thursday, March 11, 2021
Mayo Clinic, Minnesota, Mayo Clinic Alix School of Medicine, Mayo, States of the United States, Midwestern United States

11, 2021 /PRNewswire-PRWeb/ -- MicroSalt is pleased to announce a new member of its advisory board.

Key Points: 
  • 11, 2021 /PRNewswire-PRWeb/ -- MicroSalt is pleased to announce a new member of its advisory board.
  • Shah joins MicroSalt Inc. as a medical advisor who will provide valuable insight as the MicroSalt team continues forward on its mission to reduce sodium consumption and offer healthier alternatives for consumers.
  • "We're excited to have Dr. Shah join our advisory board," said Victor Hugo Manzanilla, CEO of MicroSalt.
  • Dr. Shah comes to the team with more than a decade of experience in cardiovascular medicine, and currently serves as a senior associate consultant with the Mayo Clinic and assistant professor at Mayo Clinic Alix School of Medicine.

ScholarRx Welcomes Dr. Adi Haramati to Academic Advisory Board

Retrieved on: 
Thursday, March 4, 2021
Prober, Mayo Clinic, Minnesota, States of the United States

LOUISVILLE, Ky., March 4, 2021 /PRNewswire/ -- ScholarRx is pleased to announce that Dr. Aviad "Adi" Haramati has joined the ScholarRx Academic Advisory Board, which is chaired by Dr. Charles Prober of Stanford University.

Key Points: 
  • LOUISVILLE, Ky., March 4, 2021 /PRNewswire/ -- ScholarRx is pleased to announce that Dr. Aviad "Adi" Haramati has joined the ScholarRx Academic Advisory Board, which is chaired by Dr. Charles Prober of Stanford University.
  • He received a PhD in Physiology from the University of Cincinnati and trained at Mayo Clinic before coming to Georgetown.
  • He is Chair-elect of the Council of Faculty and Academic Societies of the AAMC and currently serves on the AAMC Board of Directors.
  • "I am thrilled that Adi has agreed to join our ScholarRx Academic Advisory Board," said Dr. Prober.

Harmony Healthcare Names Lisa Knowles as Senior Director, Client Solutions

Retrieved on: 
Thursday, February 25, 2021
Mayo Clinic, Minnesota, States of the United States

TAMPA, Fla., Feb. 25, 2021 /PRNewswire-PRWeb/ -- Harmony Healthcare , a trusted provider of consultants within population health and reimbursement to health systems, has named Lisa Knowles to its leadership team as Senior Director of Client Solutions.

Key Points: 
  • TAMPA, Fla., Feb. 25, 2021 /PRNewswire-PRWeb/ -- Harmony Healthcare , a trusted provider of consultants within population health and reimbursement to health systems, has named Lisa Knowles to its leadership team as Senior Director of Client Solutions.
  • Knowles has 20 years of leadership experience at large healthcare centers including Sutter, Mayo Clinic, Stanford, and the Cleveland Clinic.
  • "I'm excited to join Harmony Healthcare and bring the knowledge I've gained to this dynamic team to contribute to its growth," Knowles said.
  • "Harmony has a deep bandwidth of knowledgeable and skilled consultants to lead our various solutions in partnership with our clients.

Charles E. Crutchfield III, MD of Crutchfield Dermatology, was named a Top Doctor in Mpls. St. Paul Magazine, 2021

Retrieved on: 
Monday, February 22, 2021
Dermatology, Mayo Clinic, Minnesota, States of the United States

EAGAN, Minn., Feb. 22, 2021 /PRNewswire-PRWeb/ --Charles E. Crutchfield III, MD of Crutchfield Dermatology, was named a Top Doctor in Mpls.

Key Points: 
  • EAGAN, Minn., Feb. 22, 2021 /PRNewswire-PRWeb/ --Charles E. Crutchfield III, MD of Crutchfield Dermatology, was named a Top Doctor in Mpls.
  • St. Paul Magazine's Top Doctors rankings are determined by a survey sent to 5,000 physicians and nurses in the metro area.
  • I truly appreciate their recognition and confidence in naming me for this best skincare honor," said Dr. Crutchfield, Eagan Dermatologist.
  • Charles E. Crutchfield III, M.D., is a graduate of the Mayo Clinic Medical School and a Clinical Professor of Dermatology at the University of Minnesota Medical School.